.
.
.
.

Coronavirus: Russia says its second COVID-19 vaccine is 100 pct effective

Published: Updated:

Russia’s consumer health watchdog Rospotrebnadzor on Tuesday said Russia’s second vaccine against COVID-19 is 100 percent effective based on the results of clinical trials, the TASS news agency reported.

Visit our dedicated coronavirus site here for all the latest updates.

Russia began mass trials of EpiVacCorona, which is being developed by Siberia’s Vector Institute, in November.

Moscow has said its other approved COVID-19 vaccine, Sputnik V, is 92 percent effective at protecting people from COVID-19 according to interim results.

Read more:

Coronavirus: Russia says 1.5 mln people received Sputnik vaccine worldwide

Coronavirus: Russia ready to trial combined AstraZeneca, Sputnik V vaccine in Ukraine

Pandemic over by May in countries that mass-inoculate with Sputnik V vaccine: RDIF